Schonfeld Strategic Advisors

Inventiva Pharma is a clinical-stage biopharmaceutical company based in France, dedicated to developing oral small molecule therapies for patients with significant unmet medical needs, particularly in fibrosis, lysosomal storage disorders, and oncology. The company specializes in drugs that target nuclear receptors, transcription factors, and epigenetic modulation. Its primary product candidate, lanifibranor, is being developed for the treatment of non-alcoholic steatohepatitis (NASH), a condition currently lacking approved therapies. Inventiva has established a robust pipeline supported by a proprietary discovery engine, a dedicated research and development facility, and a skilled team with extensive experience in drug development. In addition to advancing lanifibranor, the company is also working on several earlier-stage programs aimed at addressing various medical conditions. All operations are conducted in France.

Outlook Therapeutics, Inc. is a late clinical-stage biopharmaceutical company based in Cranbury, New Jersey, specializing in the development and commercialization of monoclonal antibodies for ophthalmic conditions. The company's primary product candidate, ONS-5010, is a proprietary formulation of bevacizumab currently undergoing Phase-III clinical trials aimed at treating wet age-related macular degeneration, diabetic macular edema, and branch retinal vein occlusion, among other retinal diseases. Outlook Therapeutics has established collaboration and license agreements with several partners, including IPCA Laboratories Limited and Laboratorios Liomont, among others. Originally incorporated in 2010 as Oncobiologics, the company rebranded to its current name in November 2018 to better reflect its focus on ophthalmic therapeutics.

Bolt is a company dedicated to enhancing e-commerce by providing a streamlined checkout experience. Founded in 2014 and headquartered in San Francisco, Bolt offers a platform that enables retailers to facilitate secure, one-click checkouts for their customers, eliminating the need for passwords or repeated personal information. This approach not only simplifies the purchasing process but also improves conversion rates and customer retention for businesses. A growing number of retailers, including well-known brands such as REVOLVE, Casper, Badgley Mischka, and Benefit Cosmetics, utilize Bolt's services to meet the demand for efficient and user-friendly online shopping experiences. By democratizing commerce, Bolt aims to strengthen the connection between retailers and their customers.

Inxeption Corporation is a technology company that operates a cloud-based e-commerce platform tailored for industrial and supply chain businesses. Founded in 2017 and headquartered in South San Francisco, California, Inxeption's platform integrates tools and blockchain technology to facilitate the promotion, sale, and management of products and services online. It offers solutions such as PRODUCT LEDGER, which centralizes and digitizes product information, enabling companies of all sizes to enhance their sales, improve operational visibility, and achieve cost efficiencies. Through the Inxeption B2B marketplace, businesses can access new online commerce channels and applications that streamline logistics and other operations, fostering a more efficient industrial commerce environment.

Innovaccer Inc. is a technology company that specializes in developing analytical and data science applications primarily for the healthcare sector, along with industries such as financial services, manufacturing, and retail. The company offers a comprehensive Healthcare Intelligence Cloud that aggregates and analyzes patient data from various sources, including electronic health records and medical devices, to provide actionable insights. Its suite of solutions includes Datashop, which encompasses tools for patient care management, risk assessment in financial markets, and healthcare trend analysis. Innovaccer's platforms facilitate improved clinical workflows, care coordination, and operational efficiency by integrating functionalities for population health management and billing processes. Founded in 2012 and headquartered in Noida, India, with an office in Palo Alto, California, Innovaccer serves a diverse clientele, including academic institutions and governmental organizations, both domestically and internationally.

Automattic Inc., established in 2005 and headquartered in San Francisco, specializes in developing and providing web-based solutions. It is renowned for its suite of products, including WordPress.com for website creation and management, WooCommerce for e-commerce, and Jetpack for site performance and security. Automattic serves non-profit and open-source projects globally, with a mission to democratize publishing and commerce through its open-source content management systems.

Unqork Inc. is a New York-based company that operates a no-code enterprise application platform, designed to assist financial and insurance sectors in managing their client lifecycle. Founded in 2016, Unqork enables organizations to build, deploy, and manage complex applications without the need for traditional coding. This approach allows large enterprises to create custom software more efficiently and at a lower cost compared to conventional methods. The platform not only streamlines the product sales process but also enhances customer experience across various industries, including real estate, government, education, and healthcare. Unqork's innovative solutions significantly improve the quality and speed of software development for its clients.

Poseida Therapeutics is a clinical-stage biopharmaceutical company based in San Diego, California, dedicated to developing innovative therapeutics for patients with significant unmet medical needs. The company utilizes non-viral gene engineering technologies to create a pipeline of targeted therapies, including both autologous and allogeneic chimeric antigen receptor T cell (CAR-T) product candidates aimed at treating hematological malignancies and solid tumors. Additionally, Poseida is advancing gene therapies for rare and life-threatening conditions, such as Ornithine transcarbamylase deficiency, methylmalonic acidemia, and various genetic liver diseases. Founded in 2014, Poseida is committed to addressing critical health challenges through its focused research and development efforts.

AvidXchange, Inc. is a leading provider of accounts payable automation and payment solutions specifically designed for mid-sized companies in various sectors, including banking, construction, healthcare, hospitality, real estate, and technology. Founded in 2000 and headquartered in Charlotte, North Carolina, AvidXchange streamlines invoice and payment processes, processing over $140 billion in transactions annually through a network of more than 680,000 suppliers. The company's comprehensive software suite includes tools for purchase order management, invoice handling, payment processing, check printing, and utility bill management. With a workforce of approximately 1,500 employees and additional offices in several states, AvidXchange has established itself as a prominent player in the fintech space, transforming how approximately 6,000 customers across North America manage their accounts payable and payment workflows.